arrow
B

Bambi Grilley

texas children’s hospital and houston methodist hospital
H指数:35
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventions

国际细胞与基因治疗学会扩展性准入工作组立场文件:支持对研究性细胞与基因治疗干预措施进行公平且合乎伦理的扩展性准入的关键考量

2025-02-070
OAAI
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified fi ed Cell Therapies
2024-08-012
PRE
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

晚期肉瘤淋巴细胞清除后自体HER2-specific CAR T细胞: 1期临床试验

2024-04-247
OA
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results (vol 29, pg 1379, 2023)
2024-01-090
OA
International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products

国际细胞与基因治疗学会立场文件: 支持基于证据的细胞和基因疗法的关键考虑因素,反对未经证实的产品的营销

2023-09-0111
OAAI
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Car-nkt细胞在复发或难治性神经母细胞瘤中的Anti-GD2: 更新的1期试验中期结果

2023-05-1556
PRE
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
2023-03-016
OAAI
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

多抗原靶向T细胞疗法治疗复发/难治性乳腺癌

2022-07-157
OAAI
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma
2020-07-2928
PREAI
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
2020-07-15112
OAAI